Skip to main content
News

Asthma Drugs Discontinued


May 25, 2016

Major Pharmaceuticals is discontinuing three presentations of theophylline extended-release tablets, according to an ASHP report.

The following presentations are impacted: 

Presentation

NDC

100 mg

00904-5887-61

200 mg

00904-5888-61

300 mg

00904-5889-61

 

In April, Teva Pharmaceuticals announced that a number of presentations of the medication would not be available until 2018. They noted that the delay was caused by meeting requirements associated with good manufacturing practices. Also in April, Heritage Pharma announced that it was discontinuing two presentations of the medication. 

Click here to read the ASHP report.

 

--Stephanie Vaccaro

 

Reference:

1. ASHP. Theophylline extended-release tablets. www.ashp.org. Accessed May 19, 2016. 

Back to Top